Dysregulation of AHR by either genetic deficiency or by excess activity of the downstream negative regulator Cyp1a1 causes skin pathology, and patients suffering from psoriasis display reduced activity of the AHR pathway and increased enzymatic activity of Cyp1a1 compared with healthy donors (Kyoreva et al, 2021). The gene discussed is AHR; the disease is psoriasis.